{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:58:47Z","timestamp":1781643527939,"version":"3.54.5"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manchester University NHS Foundation Trust Clinical Research Fellowship"},{"name":"NIHR Research Professorship","award":["NIHR304303"],"award-info":[{"award-number":["NIHR304303"]}]},{"DOI":"10.13039\/100014653","name":"NIHR Manchester Biomedical Research Centre","doi-asserted-by":"crossref","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lynch syndrome is a hereditary cancer predisposition condition associated with an elevated lifetime risk of colorectal, endometrial, ovarian, and several other malignancies. This review provides an updated overview of evidence-based prevention strategies for gynaecological cancers in patients with Lynch syndrome. Risk-reducing hysterectomy with bilateral salpingo-oophorectomy is the most effective intervention for lowering cancer incidence and mortality, but is associated with surgical morbidity and requires careful consideration of reproductive plans and the adverse consequences of premature menopause. Gynaecological surveillance using transvaginal ultrasound and endometrial biopsy is widely implemented as an alternative; however, available evidence is heterogeneous and indicates no benefit in reducing mortality. Novel approaches\u2014such as biomarker-based detection using DNA methylation analysis of cervicovaginal samples, liquid biopsy techniques, and microbiome profiling\u2014offer promising, non-invasive alternatives but require prospective validation in Lynch-specific populations. Chemoprevention with hormonal agents and aspirin may reduce cancer risk, while vaccine-based prevention strategies are under active investigation. Adoption of a healthy lifestyle is recommended for overall health, although its impact on gynaecological cancer risk in Lynch syndrome remains uncertain. Future research should prioritise prospective trials to establish optimal cancer prevention protocols, validate novel biomarkers and preventive cancer vaccine strategies, and evaluate the long-term effectiveness, acceptability, and cost-effectiveness of combined preventive approaches to improve outcomes in this high hereditary-risk population.<\/jats:p>","DOI":"10.1007\/s10689-026-00548-1","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:08:58Z","timestamp":1774354138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevention strategies for hereditary gynaecological cancer in Lynch syndrome"],"prefix":"10.1007","volume":"25","author":[{"given":"Kevin J. J.","family":"Kwinten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Ellen","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"van Altena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoline","family":"Hoogerbrugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma J.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne A.","family":"de Hullu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"1","key":"548_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0004.2009.01230.x","volume":"76","author":"HT Lynch","year":"2009","unstructured":"Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR (2009) Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76(1):1\u201318","journal-title":"Clin Genet"},{"issue":"1","key":"548_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.giec.2021.08.002","volume":"32","author":"LH Biller","year":"2022","unstructured":"Biller LH, Creedon SA, Klehm M, Yurgelun MB (2022) Lynch Syndrome-Associated Cancers Beyond Colorectal Cancer. Gastrointest Endosc Clin N Am 32(1):75\u201393","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"548_CR3","doi-asserted-by":"publisher","first-page":"101909","DOI":"10.1016\/j.eclinm.2023.101909","volume":"58","author":"M Dominguez-Valentin","year":"2023","unstructured":"Dominguez-Valentin M, Haupt S, Sepp\u00e4l\u00e4 TT, Sampson JR, Sunde L, Bernstein I et al (2023) Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database. EClinicalMedicine 58:101909","journal-title":"EClinicalMedicine"},{"issue":"4","key":"548_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10689-024-00414-y","volume":"23","author":"J Castillo-Iturra","year":"2024","unstructured":"Castillo-Iturra J, S\u00e1nchez A, Balaguer F (2024) Colonoscopic surveillance in Lynch syndrome: guidelines in perspective. Fam Cancer 23(4):459\u2013468","journal-title":"Fam Cancer"},{"issue":"10","key":"548_CR5","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/s41436-019-0489-y","volume":"21","author":"EJ Crosbie","year":"2019","unstructured":"Crosbie EJ, Ryan NAJ, Arends MJ, Bosse T, Burn J, Cornes JM et al (2019) The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. Genet Med 21(10):2390\u20132400","journal-title":"Genet Med"},{"key":"548_CR6","unstructured":"VKNG Erfelijke darmkanker: Lynch syndroom, polyposis en familiair darmkanker 2025 [cited 2025 29th of October]. Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/erfelijke_darmkanker_lynch_syndroom_polyposis_en_familiair_darmkanker\/startpagina_richtlijn_erfelijke_darmkanker_lynch_syndroom_polyposis_en_familiair_darmkanker.html"},{"issue":"1","key":"548_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","volume":"31","author":"N Concin","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S et al (2021) ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 31(1):12\u201339","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"548_CR8","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","volume":"62","author":"HF Vasen","year":"2013","unstructured":"Vasen HF, Blanco I, Aktan-Collan K, Gopie JP, Alonso A, Aretz S et al (2013) Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 62(6):812\u2013823","journal-title":"Gut"},{"issue":"8","key":"548_CR9","doi-asserted-by":"publisher","first-page":"e423","DOI":"10.1016\/S1470-2045(25)00167-6","volume":"26","author":"N Concin","year":"2025","unstructured":"Concin N, Matias-Guiu X, Cibula D, Colombo N, Creutzberg CL, Ledermann J et al (2025) ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025. Lancet Oncol 26(8):e423\u2013e35","journal-title":"Lancet Oncol"},{"issue":"3","key":"548_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1056\/NEJMoa052627","volume":"354","author":"KM Schmeler","year":"2006","unstructured":"Schmeler KM, Lynch HT, Chen L-m, Munsell MF, Soliman PT, Clark MB et al (2006) Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome. N Engl J Med 354(3):261\u2013269","journal-title":"N Engl J Med"},{"issue":"3","key":"548_CR11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ygyno.2018.11.027","volume":"152","author":"CC Sun","year":"2019","unstructured":"Sun CC, Meyer LA, Daniels MS, Bodurka DC, Nebgen DR, Burton-Chase AM et al (2019) Women\u2019s preferences for cancer risk management strategies in Lynch syndrome. Gynecol Oncol 152(3):514\u2013521","journal-title":"Gynecol Oncol"},{"issue":"4","key":"548_CR12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/1471-0528.16432","volume":"128","author":"N Ryan","year":"2021","unstructured":"Ryan N, Nobes M, Sedgewick D, Teoh SN, Evans DG, Crosbie EJ (2021) A mismatch in care: results of a United Kingdom-wide patient and clinician survey of gynaecological services for women with Lynch syndrome. BJOG 128(4):728\u2013736","journal-title":"BJOG"},{"issue":"10","key":"548_CR13","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1093\/annonc\/mdz233","volume":"30","author":"N Stjepanovic","year":"2019","unstructured":"Stjepanovic N, Moreira L, Carneiro F, Balaguer F, Cervantes A, Balma\u00f1a J et al (2019) Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol 30(10):1558\u20131571","journal-title":"Ann Oncol"},{"issue":"10","key":"548_CR14","doi-asserted-by":"publisher","first-page":"695","DOI":"10.6004\/jnccn.2024.0061","volume":"22","author":"R Hodan","year":"2024","unstructured":"Hodan R, Gupta S, Weiss JM, Axell L, Burke CA, Chen LM et al (2024) Genetic\/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw 22(10):695\u2013711","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"548_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","volume":"31","author":"N Concin","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S et al (2021) ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecologic Cancer 31(1):12","journal-title":"Int J Gynecologic Cancer"},{"key":"548_CR16","unstructured":"Online eCT (2024) [Available from: https:\/\/www.eviq.org.au\/"},{"key":"548_CR17","unstructured":"Group UCG (2020) UKCGG consensus group guidelines for the management of Lynch syndrome: UK Cancer Genetics Group; [Available from: https:\/\/www.ukcgg.org"},{"issue":"5","key":"548_CR18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/ijgc-2021-003132","volume":"32","author":"N Lim","year":"2022","unstructured":"Lim N, Hickey M, Young GP, Macrae FA, Kelly C (2022) Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review. Int J Gynecologic Cancer 32(5):646\u2013655","journal-title":"Int J Gynecologic Cancer"},{"issue":"6","key":"548_CR19","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/cncr.10380","volume":"94","author":"I Dove-Edwin","year":"2002","unstructured":"Dove-Edwin I, Boks D, Goff S, Kenter GG, Carpenter R, Vasen HF et al (2002) The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer 94(6):1708\u20131712","journal-title":"Cancer"},{"issue":"4","key":"548_CR20","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/ijc.22446","volume":"120","author":"L Renkonen-Sinisalo","year":"2007","unstructured":"Renkonen-Sinisalo L, B\u00fctzow R, Leminen A, Lehtovirta P, Mecklin JP, J\u00e4rvinen HJ (2007) Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer 120(4):821\u2013824","journal-title":"Int J Cancer"},{"issue":"1","key":"548_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0090-8258(03)00371-8","volume":"91","author":"FE Rijcken","year":"2003","unstructured":"Rijcken FE, Mourits MJ, Kleibeuker JH, Hollema H, van der Zee AG (2003) Gynecologic screening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 91(1):74\u201380","journal-title":"Gynecol Oncol"},{"issue":"6","key":"548_CR22","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/j.1525-1438.2007.01183.x","volume":"18","author":"F L\u00e9curu","year":"2008","unstructured":"L\u00e9curu F, Le Fr\u00e8re Belda MA, Bats AS, Tulpin L, Metzger U, Olschwang S et al (2008) Performance of office hysteroscopy and endometrial biopsy for detecting endometrial disease in women at risk of human non-polyposis colon cancer: a prospective study. Int J Gynecol Cancer 18(6):1326\u20131331","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"548_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10689-009-9252-x","volume":"8","author":"LH Gerritzen","year":"2009","unstructured":"Gerritzen LH, Hoogerbrugge N, Oei AL, Nagengast FM, van Ham MA, Massuger LF et al (2009) Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome. Fam Cancer 8(4):391\u2013397","journal-title":"Fam Cancer"},{"issue":"28","key":"548_CR24","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1200\/JCO.2009.23.7784","volume":"27","author":"HJ J\u00e4rvinen","year":"2009","unstructured":"J\u00e4rvinen HJ, Renkonen-Sinisalo L, Akt\u00e1n-Coll\u00e1n K, Peltom\u00e4ki P, Aaltonen LA, Mecklin J-P (2009) Ten Years After Mutation Testing for Lynch Syndrome: Cancer Incidence and Outcome in Mutation-Positive and Mutation-Negative Family Members. J Clin Oncol 27(28):4793\u20134797","journal-title":"J Clin Oncol"},{"issue":"4","key":"548_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/IGC.0b013e3181d7283a","volume":"20","author":"F L\u00e9curu","year":"2010","unstructured":"L\u00e9curu F, Huchon C, Metzger U, Bats AS, Le Fr\u00e8re Belda MA, Olschwang S et al (2010) Contribution of Ultrasonography to Endometrial Cancer Screening in Patients With Hereditary Nonpolyposis Colorectal Cancer\/Lynch Syndrome. Int J Gynecol Cancer 20(4):583\u2013587","journal-title":"Int J Gynecol Cancer"},{"issue":"15suppl","key":"548_CR26","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1200\/jco.2011.29.15_suppl.1559","volume":"29","author":"C Guillen-Ponce","year":"2011","unstructured":"Guillen-Ponce C, Martinez-Sevila C, Perea R, Arenas M, Molina-Garrido MJ, Goicoechea M et al (2011) Gynecologic cancer screening in women at high risk of Lynch syndrome. J Clin Oncol 29(15suppl):1559","journal-title":"J Clin Oncol"},{"issue":"6","key":"548_CR27","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s00404-012-2492-2","volume":"286","author":"R Manchanda","year":"2012","unstructured":"Manchanda R, Saridogan E, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E et al (2012) Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC\/Lynch syndrome (LS). Arch Gynecol Obstet 286(6):1555\u20131562","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"548_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1399-0004.2012.01929.x","volume":"83","author":"S Stuckless","year":"2013","unstructured":"Stuckless S, Green J, Dawson L, Barrett B, Woods MO, Dicks E et al (2013) Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation: Gynecological screening in MSH2 mutation carriers. Clin Genet 83(4):359\u2013364","journal-title":"Clin Genet"},{"issue":"2","key":"548_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ygyno.2013.05.032","volume":"131","author":"JM Helder-Woolderink","year":"2013","unstructured":"Helder-Woolderink JM, De Bock GH, Sijmons RH, Hollema H, Mourits MJE (2013) The additional value of endometrial sampling in the early detection of endometrial cancer in women with Lynch syndrome. Gynecol Oncol 131(2):304\u2013308","journal-title":"Gynecol Oncol"},{"issue":"3","key":"548_CR30","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ygyno.2014.03.012","volume":"133","author":"Z Ketabi","year":"2014","unstructured":"Ketabi Z, Gerdes A-M, Mosgaard B, Ladelund S, Bernstein I (2014) The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer. Gynecol Oncol 133(3):526\u2013530","journal-title":"Gynecol Oncol"},{"issue":"1","key":"548_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ygyno.2014.08.017","volume":"135","author":"DR Nebgen","year":"2014","unstructured":"Nebgen DR, Lu KH, Rimes S, Keeler E, Broaddus R, Munsell MF et al (2014) Combined colonoscopy and endometrial biopsy cancer screening results in women with Lynch syndrome. Gynecol Oncol 135(1):85\u201389","journal-title":"Gynecol Oncol"},{"issue":"3","key":"548_CR32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ygyno.2015.07.016","volume":"138","author":"G Tzortzatos","year":"2015","unstructured":"Tzortzatos G, Andersson E, Soller M, Askmalm MS, Zagoras T, Georgii-Hemming P et al (2015) The gynecological surveillance of women with Lynch syndrome in Sweden. Gynecol Oncol 138(3):717\u2013722","journal-title":"Gynecol Oncol"},{"key":"548_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ygyno.2016.04.094","volume":"141","author":"C Cornou","year":"2016","unstructured":"Cornou C, Bats AS, Vannieuwenhuyse G, Capmas P, Bensaid C, Ng\u00f4 C et al (2016) Impact of gynecologic screening in Lynch syndrome. Gynecol Oncol 141:27","journal-title":"Gynecol Oncol"},{"key":"548_CR34","doi-asserted-by":"crossref","unstructured":"Due\u00f1as N, Navarro M, Teul\u00e9 \u00c0, Solanes A, Salinas M, Iglesias S et al (2020) Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals. Cancers [Internet] ; 12(11)","DOI":"10.3390\/cancers12113419"},{"issue":"3","key":"548_CR35","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/cancers13030459","volume":"13","author":"EL Eikenboom","year":"2021","unstructured":"Eikenboom EL, van Doorn HC, Dinjens WNM, Dubbink HJ, Geurts-Giele W, Spaander MCW et al (2021) Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers. Cancers 13(3):459","journal-title":"Cancers"},{"key":"548_CR36","doi-asserted-by":"crossref","unstructured":"Eikenboom EL, van Leeuwen L, Groenendijk F, Woolderink JM, Van Altena AM, Van Leerdam ME et al (2025) Outcomes of endometrial cancer prevention strategies in patients with Lynch syndrome: a nationwide cohort study in the Netherlands. eClinicalMedicine. ;79","DOI":"10.1016\/j.eclinm.2024.103006"},{"key":"548_CR37","doi-asserted-by":"crossref","unstructured":"de Jong AE, Hendriks YM, Kleibeuker JH, de Boer SY, Cats A, Griffioen G (2006) Decrease in mortality in Lynch syndrome families because of surveillance. 130:665\u2013671","DOI":"10.1053\/j.gastro.2005.11.032"},{"issue":"2","key":"548_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10689-020-00158-5","volume":"19","author":"MH Kalamo","year":"2020","unstructured":"Kalamo MH, M\u00e4enp\u00e4\u00e4 JU, Sepp\u00e4l\u00e4 TT, Mecklin JP, Huhtala H, Sorvettula K et al (2020) Factors associated with decision-making on prophylactic hysterectomy and attitudes towards gynecological surveillance among women with Lynch syndrome (LS): a descriptive study. Fam Cancer 19(2):177\u2013182","journal-title":"Fam Cancer"},{"issue":"4","key":"548_CR39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10689-009-9259-3","volume":"8","author":"K Elmasry","year":"2009","unstructured":"Elmasry K, Davies AJ, Evans DG, Seif MN, Reynolds K (2009) Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study. Fam Cancer 8(4):431\u2013439","journal-title":"Fam Cancer"},{"issue":"1","key":"548_CR40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13053-019-0123-7","volume":"17","author":"KM McGarragle","year":"2019","unstructured":"McGarragle KM, Aronson M, Semotiuk K, Holter S, Hare CJ, Ferguson SE et al (2019) Patient-physician relationships, health self-efficacy, and gynecologic cancer screening among women with Lynch syndrome. Hereditary cancer Clin Pract 17(1):24","journal-title":"Hereditary cancer Clin Pract"},{"issue":"10333","key":"548_CR41","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","volume":"399","author":"EJ Crosbie","year":"2022","unstructured":"Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N (2022) Endometrial cancer. Lancet 399(10333):1412\u20131428","journal-title":"Lancet"},{"key":"548_CR42","doi-asserted-by":"publisher","first-page":"108576","DOI":"10.1016\/j.pec.2024.108576","volume":"131","author":"H Huband","year":"2025","unstructured":"Huband H, McGarragle KM, Hare CJ, Aronson M, Ward T, Semotiuk K et al (2025) Gynecologic cancer screening among women with Lynch syndrome: Information and healthcare access needs. Patient Educ Couns 131:108576","journal-title":"Patient Educ Couns"},{"issue":"2","key":"548_CR43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10689-016-9937-x","volume":"16","author":"J Helder-Woolderink","year":"2017","unstructured":"Helder-Woolderink J, de Bock G, Hollema H, van Oven M, Mourits M (2017) Pain evaluation during gynaecological surveillance in women with Lynch syndrome. Fam Cancer 16(2):205\u2013210","journal-title":"Fam Cancer"},{"issue":"12","key":"548_CR44","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1034\/j.1600-0412.2001.801210.x","volume":"80","author":"E Epstein","year":"2001","unstructured":"Epstein E, Ramirez A, Skoog L, Valentin L (2001) Dilatation and curettage fails to detect most focal lesions in the uterine cavity in women with postmenopausal bleeding. Acta Obstet Gynecol Scand 80(12):1131\u20131136","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"548_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1067\/mob.2001.108332","volume":"184","author":"G Gebauer","year":"2001","unstructured":"Gebauer G, Hafner A, Siebzehnr\u00fcbl E, Lang N (2001) Role of hysteroscopy in detection and extraction of endometrial polyps: results of a prospective study. Am J Obstet Gynecol 184(2):59\u201363","journal-title":"Am J Obstet Gynecol"},{"key":"548_CR46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejogrb.2015.12.008","volume":"197","author":"N van Hanegem","year":"2016","unstructured":"van Hanegem N, Prins MM, Bongers MY, Opmeer BC, Sahota DS, Mol BW et al (2016) The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 197:147\u2013155","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"548_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10689-007-9123-2","volume":"6","author":"F L\u00e9curu","year":"2007","unstructured":"L\u00e9curu F, Metzger U, Scarabin C, Le Fr\u00e8re Belda MA, Olschwang S, Laurent Puig P (2007) Hysteroscopic findings in women at risk of HNPCC. Results of a prospective observational study. Fam Cancer 6(3):295\u2013299","journal-title":"Fam Cancer"},{"key":"548_CR48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejogrb.2021.11.423","volume":"270","author":"J Morrison","year":"2022","unstructured":"Morrison J, Balega J, Buckley L, Clamp A, Crosbie E, Drew Y et al (2022) British Gynaecological Cancer Society (BGCS) uterine cancer guidelines: Recommendations for practice. Eur J Obstet Gynecol Reprod Biol 270:50\u201389","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"548_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1200\/JOP.2010.000038","volume":"7","author":"BM Huang","year":"2011","unstructured":"Huang BM, Sun C, Boyd-Rogers S, Burzawa J, Milbourne A, Keeler E et al (2011) Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: A patient-centered approach. J Oncol Pract 7(1):43\u201347","journal-title":"J Oncol Pract"},{"issue":"2","key":"548_CR50","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1525-1438.2007.01009.x","volume":"18","author":"NJ Wood","year":"2008","unstructured":"Wood NJ, Munot S, Sheridan E, Duffy SR (2008) Does a one-stop gynecology screening clinic for women in hereditary nonpolyposis colorectal cancer families have an impact on their psychological morbidity and perception of health? Int J Gynecol Cancer 18(2):279\u2013284","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"548_CR51","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10689-011-9444-z","volume":"10","author":"KY Yang","year":"2011","unstructured":"Yang KY, Caughey AB, Little SE, Cheung MK, Chen L-M (2011) A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) Families. Fam Cancer 10(3):535\u2013543","journal-title":"Fam Cancer"},{"issue":"2","key":"548_CR52","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/cncr.23554","volume":"113","author":"JS Kwon","year":"2008","unstructured":"Kwon JS, Sun CC, Peterson SK, White KG, Daniels MS, Boyd-Rogers SG et al (2008) Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome. Cancer 113(2):326\u2013335","journal-title":"Cancer"},{"issue":"41","key":"548_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/VBXX6307","volume":"28","author":"TM Snowsill","year":"2024","unstructured":"Snowsill TM, Coelho H, Morrish NG, Briscoe S, Boddy K, Smith T et al (2024) Gynaecological cancer surveillance for women with Lynch syndrome: systematic review and cost-effectiveness evaluation. Health Technol Assess 28(41):1\u2013228","journal-title":"Health Technol Assess"},{"issue":"28","key":"548_CR54","doi-asserted-by":"publisher","first-page":"6890","DOI":"10.1200\/JCO.2005.02.626","volume":"23","author":"JB Madalinska","year":"2005","unstructured":"Madalinska JB, Hollenstein J, Bleiker E, van Beurden M, Valdimarsdottir HB, Massuger LF et al (2005) Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 23(28):6890\u20136898","journal-title":"J Clin Oncol"},{"issue":"1","key":"548_CR55","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1111\/1471-0528.16896","volume":"129","author":"R Manchanda","year":"2022","unstructured":"Manchanda R, Gaba F, Talaulikar V, Pundir J, Gessler S, Davies M et al (2022) Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause. BJOG: Int J Obstet Gynecol 129(1):e16\u2013e34","journal-title":"BJOG: Int J Obstet Gynecol"},{"issue":"4","key":"548_CR56","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/AOG.0b013e3182864350","volume":"121","author":"WH Parker","year":"2013","unstructured":"Parker WH, Feskanich D, Broder MS, Chang E, Shoupe D, Farquhar CM et al (2013) Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses\u2019 health study. Obstet Gynecol 121(4):709\u2013716","journal-title":"Obstet Gynecol"},{"issue":"1","key":"548_CR57","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13053-015-0031-4","volume":"13","author":"H Etchegary","year":"2015","unstructured":"Etchegary H, Dicks E, Watkins K, Alani S, Dawson L (2015) Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers. Hereditary Cancer Clin Pract 13(1):10","journal-title":"Hereditary Cancer Clin Pract"},{"key":"548_CR58","unstructured":"Dominguez-Valentin M, Sepp\u00e4l\u00e4 TT, Engel C, Aretz S, Macrae F, Winship I et al (2020) Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database. J Clin Med. ;9(7)"},{"issue":"4","key":"548_CR59","first-page":"705","volume":"23","author":"M Dominguez-Valentin","year":"2021","unstructured":"Dominguez-Valentin M, Crosbie EJ, Engel C, Aretz S, Macrae F, Winship I et al (2021) Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report. Genet Sci 23(4):705\u2013712","journal-title":"Genet Sci"},{"key":"548_CR60","doi-asserted-by":"crossref","unstructured":"Capasso I, Santoro A, Lucci Cordisco E, Perrone E, Tronconi F, Catena U et al (2023) Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer. Cancers (Basel). ;15(5)","DOI":"10.3390\/cancers15051400"},{"issue":"1","key":"548_CR61","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/aogs.12516","volume":"94","author":"C Madsen","year":"2015","unstructured":"Madsen C, Baandrup L, Dehlendorff C, Kjaer SK (2015) Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study. Acta Obstet Gynecol Scand 94(1):86\u201394","journal-title":"Acta Obstet Gynecol Scand"},{"key":"548_CR62","doi-asserted-by":"crossref","unstructured":"Falconer H, Yin L, Gr\u00f6nberg H, Altman D (2015) Ovarian cancer risk after salpingectomy: a nationwide population-based study. J Natl Cancer Inst. ;107(2)","DOI":"10.1093\/jnci\/dju410"},{"issue":"6","key":"548_CR63","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3892\/mco.2014.397","volume":"2","author":"K Nakamura","year":"2014","unstructured":"Nakamura K, Banno K, Yanokura M, Iida M, Adachi M, Masuda K et al (2014) Features of ovarian cancer in Lynch syndrome (Review). Mol Clin Oncol 2(6):909\u2013916","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"548_CR64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10689-014-9761-0","volume":"14","author":"R Moldovan","year":"2015","unstructured":"Moldovan R, Keating S, Clancy T (2015) The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome. Fam Cancer 14(1):51\u201360","journal-title":"Fam Cancer"},{"issue":"7","key":"548_CR65","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.jmig.2020.03.002","volume":"27","author":"N Garg","year":"2020","unstructured":"Garg N, Behbehani S, Kosiorek H, Wasson M (2020) Hormone Replacement Therapy Prescription after Premature Surgical Menopause. J Minim Invasive Gynecol 27(7):1618\u20131623","journal-title":"J Minim Invasive Gynecol"},{"issue":"2","key":"548_CR66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10689-016-9937-x","volume":"16","author":"J Helder-Woolderink","year":"2017","unstructured":"Helder-Woolderink J, de Bock G, Hollema H, van Oven M, Mourits M (2017) Pain evaluation during gynaecological surveillance in women with Lynch syndrome. Fam Cancer 16(2):205\u2013210","journal-title":"Fam Cancer"},{"key":"548_CR67","doi-asserted-by":"publisher","first-page":"1127683","DOI":"10.3389\/fonc.2023.1127683","volume":"13","author":"KA Underkofler","year":"2023","unstructured":"Underkofler KA, Ring KL (2023) Updates in gynecologic care for individuals with lynch syndrome. Front Oncol 13:1127683","journal-title":"Front Oncol"},{"key":"548_CR68","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/jcm13247538","volume":"13","author":"A Asaturova","year":"2024","unstructured":"Asaturova A, Zaretsky A, Rogozhina A, Tregubova A, Badlaeva A (2024) Advancements in Minimally Invasive Techniques and Biomarkers for the Early Detection of Endometrial Cancer: A Comprehensive Review of Novel Diagnostic Approaches and Clinical Implications. J Clin Med 13:24","journal-title":"J Clin Med"},{"issue":"14","key":"548_CR69","doi-asserted-by":"publisher","first-page":"e70000","DOI":"10.1002\/cam4.70000","volume":"13","author":"KJJ Kwinten","year":"2024","unstructured":"Kwinten KJJ, Lemain VA, de Hullu JA, Leenders WPJ, Steenbeek MP, van Altena AM et al (2024) Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review. Cancer Med 13(14):e70000","journal-title":"Cancer Med"},{"issue":"11","key":"548_CR70","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/cncy.22266","volume":"128","author":"J Frias-Gomez","year":"2020","unstructured":"Frias-Gomez J, Benavente Y, Ponce J, Brunet J, Ib\u00e1\u00f1ez R, Peremiquel-Trillas P et al (2020) Sensitivity of cervico-vaginal cytology in endometrial carcinoma: A systematic review and meta-analysis. Cancer Cytopathol 128(11):792\u2013802","journal-title":"Cancer Cytopathol"},{"issue":"167","key":"548_CR71","doi-asserted-by":"publisher","first-page":"167ra4","DOI":"10.1126\/scitranslmed.3004952","volume":"5","author":"I Kinde","year":"2013","unstructured":"Kinde I, Bettegowda C, Wang Y, Wu J, Agrawal N, Shih Ie M et al (2013) Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers. Sci Transl Med 5(167):167ra4","journal-title":"Sci Transl Med"},{"key":"548_CR72","doi-asserted-by":"crossref","unstructured":"Wang Y, Li L, Douville C, Cohen JD, Yen TT, Kinde I et al (2018) Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers. Sci Transl Med. ;10(433)","DOI":"10.1126\/scitranslmed.aap8793"},{"issue":"1","key":"548_CR73","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41467-021-26615-y","volume":"13","author":"JE Barrett","year":"2022","unstructured":"Barrett JE, Jones A, Evans I, Reisel D, Herzog C, Chindera K et al (2022) The DNA methylome of cervical cells can predict the presence of ovarian cancer. Nat Commun 13(1):448","journal-title":"Nat Commun"},{"issue":"9","key":"548_CR74","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/ijc.34406","volume":"152","author":"JE Barrett","year":"2023","unstructured":"Barrett JE, Jones A, Evans I, Herzog C, Reisel D, Olaitan A et al (2023) The WID-EC test for the detection and risk prediction of endometrial cancer. Int J Cancer 152(9):1977\u20131988","journal-title":"Int J Cancer"},{"issue":"33","key":"548_CR75","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1200\/JCO.22.00266","volume":"40","author":"C Herzog","year":"2022","unstructured":"Herzog C, Mar\u00edn F, Jones A, Evans I, Reisel D, Redl E et al (2022) A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case\/Control Sets. J Clin Oncol 40(33):3828\u20133838","journal-title":"J Clin Oncol"},{"issue":"1","key":"548_CR76","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41467-021-21257-6","volume":"12","author":"H O\u2019Flynn","year":"2021","unstructured":"O\u2019Flynn H, Ryan NAJ, Narine N, Shelton D, Rana D, Crosbie EJ (2021) Diagnostic accuracy of cytology for the detection of endometrial cancer in urine and vaginal samples. Nat Commun 12(1):952","journal-title":"Nat Commun"},{"key":"548_CR77","doi-asserted-by":"crossref","unstructured":"Ramirez CAM, Stringfellow H, Naik R, Crosbie EJ, Paraskevaidi M, Rehman IU et al (2022) Infrared Spectroscopy of Urine for the Non-Invasive Detection of Endometrial Cancer. Cancers (Basel). ;14(20)","DOI":"10.3390\/cancers14205015"},{"key":"548_CR78","doi-asserted-by":"crossref","unstructured":"Herlo LF, Salcudean A, Sirli R, Iurciuc S, Herlo A, Nelson-Twakor A et al (2024) Gut Microbiota Signatures in Colorectal Cancer as a Potential Diagnostic Biomarker in the Future: A Systematic Review. Int J Mol Sci. ;25(14)","DOI":"10.3390\/ijms25147937"},{"issue":"8","key":"548_CR79","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chom.2024.07.008","volume":"32","author":"FS Baas","year":"2024","unstructured":"Baas FS, Brusselaers N, Nagtegaal ID, Engstrand L, Boleij A (2024) Navigating beyond associations: Opportunities to establish causal relationships between the gut microbiome and colorectal carcinogenesis. Cell Host Microbe 32(8):1235\u20131247","journal-title":"Cell Host Microbe"},{"issue":"1","key":"548_CR80","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12029-023-00925-4","volume":"55","author":"SB Rifkin","year":"2024","unstructured":"Rifkin SB, Sze MA, Tuck K, Koeppe E, Stoffel EM, Schloss PD (2024) Gut Microbiome Composition in Lynch Syndrome With and Without History of Colorectal Neoplasia and Non-Lynch Controls. J Gastrointest Cancer 55(1):207\u2013218","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"548_CR81","doi-asserted-by":"publisher","first-page":"20677","DOI":"10.1038\/s41598-023-47723-3","volume":"13","author":"R Naddaf","year":"2023","unstructured":"Naddaf R, Carasso S, Reznick-Levi G, Hasnis E, Qarawani A, Maza I et al (2023) Gut microbial signatures are associated with Lynch syndrome (LS) and cancer history in Druze communities in Israel. Sci Rep 13(1):20677","journal-title":"Sci Rep"},{"issue":"9","key":"548_CR82","doi-asserted-by":"publisher","first-page":"e70070","DOI":"10.1111\/jog.70070","volume":"51","author":"W Abdalla","year":"2025","unstructured":"Abdalla W, Ibrahim WN, Abdallah AM, Al-Asmakh MA, Said SS (2025) The role of the microbiome in endometrial carcinoma: Pathogenesis, biomarkers, and therapeutic prospects. J Obstet Gynaecol Res 51(9):e70070","journal-title":"J Obstet Gynaecol Res"},{"key":"548_CR83","doi-asserted-by":"crossref","unstructured":"Barczy\u0144ski B, Fr\u0105szczak K, Grywalska E, Kotarski J, Korona-G\u0142owniak I (2023) Vaginal and Cervical Microbiota Composition in Patients with Endometrial Cancer. Int J Mol Sci. ;24(9)","DOI":"10.3390\/ijms24098266"},{"issue":"1","key":"548_CR84","doi-asserted-by":"publisher","first-page":"19213","DOI":"10.1038\/s41598-019-55720-8","volume":"9","author":"DM Walsh","year":"2019","unstructured":"Walsh DM, Hokenstad AN, Chen J, Sung J, Jenkins GD, Chia N et al (2019) Postmenopause as a key factor in the composition of the Endometrial Cancer Microbiome (ECbiome). Sci Rep 9(1):19213","journal-title":"Sci Rep"},{"issue":"1","key":"548_CR85","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13027-024-00590-7","volume":"19","author":"K Javadi","year":"2024","unstructured":"Javadi K, Ferdosi-Shahandashti E, Rajabnia M, Khaledi M (2024) Vaginal microbiota and gynecological cancers: a complex and evolving relationship. Infect Agent Cancer 19(1):27","journal-title":"Infect Agent Cancer"},{"issue":"8","key":"548_CR86","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S1470-2045(19)30340-7","volume":"20","author":"NR Nen\u00e9","year":"2019","unstructured":"Nen\u00e9 NR, Reisel D, Leimbach A, Franchi D, Jones A, Evans I et al (2019) Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study. Lancet Oncol 20(8):1171\u20131182","journal-title":"Lancet Oncol"},{"key":"548_CR87","first-page":"151","volume":"8","author":"AL Beavis","year":"2016","unstructured":"Beavis AL, Smith AJ, Fader AN (2016) Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management. Int J Womens Health 8:151\u2013167","journal-title":"Int J Womens Health"},{"issue":"7630","key":"548_CR88","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","volume":"335","author":"GK Reeves","year":"2007","unstructured":"Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335(7630):1134","journal-title":"BMJ"},{"issue":"1","key":"548_CR89","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ygyno.2009.03.039","volume":"114","author":"AN Fader","year":"2009","unstructured":"Fader AN, Arriba LN, Frasure HE, von Gruenigen VE (2009) Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 114(1):121\u2013127","journal-title":"Gynecol Oncol"},{"issue":"12","key":"548_CR90","first-page":"1531","volume":"11","author":"R Kaaks","year":"2002","unstructured":"Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11(12):1531\u20131543","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"548_CR91","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1470-2045(15)00212-0","volume":"16","author":"Endometrial cancer and oral","year":"2015","unstructured":"Endometrial cancer and oral (2015) contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies. Lancet Oncol 16(9):1061\u20131070","journal-title":"Lancet Oncol"},{"issue":"6","key":"548_CR92","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ajog.2017.02.002","volume":"216","author":"L Iversen","year":"2017","unstructured":"Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC (2017) Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners\u2019 Oral Contraception Study. Am J Obstet Gynecol 216(6):580.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"548_CR93","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/1471-0528.12499","volume":"121","author":"A Orbo","year":"2014","unstructured":"Orbo A, Vereide A, Arnes M, Pettersen I, Straume B (2014) Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial. BJOG 121(4):477\u2013486","journal-title":"BJOG"},{"issue":"4","key":"548_CR94","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/IGC.0000000000000669","volume":"26","author":"MK Kim","year":"2016","unstructured":"Kim MK, Seong SJ, Kim JW, Jeon S, Choi HS, Lee IH et al (2016) Management of endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: a korean gynecologic-oncology group study. Int J Gynecol Cancer 26(4):711\u2013715","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"548_CR95","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ygyno.2018.02.006","volume":"149","author":"M Jareid","year":"2018","unstructured":"Jareid M, Thalabard JC, Aarflot M, B\u00f8velstad HM, Lund E, Braaten T (2018) Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study. Gynecol Oncol 149(1):127\u2013132","journal-title":"Gynecol Oncol"},{"key":"548_CR96","unstructured":"POET Prevention Of Endometrial Tumours 2015 [Available from: https:\/\/www.isrctn.com\/ISRCTN22037489"},{"issue":"4","key":"548_CR97","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ajog.2020.10.003","volume":"224","author":"YS Chung","year":"2021","unstructured":"Chung YS, Woo HY, Lee JY, Park E, Nam EJ, Kim S et al (2021) Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer. Am J Obstet Gynecol 224(4):370.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"548_CR98","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1158\/1940-6207.CAPR-13-0020","volume":"6","author":"KH Lu","year":"2013","unstructured":"Lu KH, Loose DS, Yates MS, Nogueras-Gonzalez GM, Munsell MF, Chen LM et al (2013) Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome. Cancer Prev Res (Phila) 6(8):774\u2013781","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"548_CR99","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/jama.2015.6789","volume":"314","author":"SG Dashti","year":"2015","unstructured":"Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP et al (2015) Female hormonal factors and the risk of endometrial cancer in lynch syndrome. JAMA 314(1):61\u201371","journal-title":"JAMA"},{"issue":"3","key":"548_CR100","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/gutjnl-2019-319915","volume":"69","author":"KJ Monahan","year":"2020","unstructured":"Monahan KJ, Bradshaw N, Dolwani S, Desouza B, Dunlop MG, East JE et al (2020) Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)\/Association of Coloproctology of Great Britain and Ireland (ACPGBI)\/United Kingdom Cancer Genetics Group (UKCGG). Gut 69(3):411\u2013444","journal-title":"Gut"},{"key":"548_CR101","doi-asserted-by":"crossref","unstructured":"Serrano D, Patrignani P, Stigliano V, Turchetti D, Sciallero S, Roviello F et al (2022) Aspirin Colorectal Cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine. Genes (Basel). ;13(3)","DOI":"10.3390\/genes13030460"},{"issue":"13","key":"548_CR102","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1002\/cncr.35297","volume":"130","author":"O Simoni","year":"2024","unstructured":"Simoni O, Scarpa M, Castagliuolo I, Stepanyan A, Angriman I, Kotsafti A et al (2024) IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer. Cancer 130(13):2272\u20132286","journal-title":"Cancer"},{"issue":"10240","key":"548_CR103","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/S0140-6736(20)30366-4","volume":"395","author":"J Burn","year":"2020","unstructured":"Burn J, Sheth H, Elliott F, Reed L, Macrae F, Mecklin JP et al (2020) Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial. Lancet 395(10240):1855\u20131863","journal-title":"Lancet"},{"issue":"5","key":"548_CR104","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/bjs.11902","volume":"108","author":"TT Sepp\u00e4l\u00e4","year":"2021","unstructured":"Sepp\u00e4l\u00e4 TT, Latchford A, Negoi I, Sampaio Soares A, Jimenez-Rodriguez R, S\u00e1nchez-Guill\u00e9n L et al (2021) European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender. Br J Surg 108(5):484\u2013498","journal-title":"Br J Surg"},{"issue":"3","key":"548_CR105","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.trecan.2016.02.004","volume":"2","author":"M Kloor","year":"2016","unstructured":"Kloor M, von Knebel Doeberitz M (2016) The Immune Biology of Microsatellite-Unstable Cancer. Trends Cancer 2(3):121\u2013133","journal-title":"Trends Cancer"},{"issue":"3","key":"548_CR106","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrclinonc.2009.237","volume":"7","author":"E Vilar","year":"2010","unstructured":"Vilar E, Gruber SB (2010) Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol 7(3):153\u2013162","journal-title":"Nat Rev Clin Oncol"},{"key":"548_CR107","doi-asserted-by":"publisher","first-page":"101204","DOI":"10.1016\/j.mam.2023.101204","volume":"93","author":"AM Bolivar","year":"2023","unstructured":"Bolivar AM, Duzagac F, Sinha KM, Vilar E (2023) Advances in vaccine development for cancer prevention and treatment in Lynch Syndrome. Mol Aspects Med 93:101204","journal-title":"Mol Aspects Med"},{"issue":"1","key":"548_CR108","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1158\/2159-8290.CD-14-0863","volume":"5","author":"NJ Llosa","year":"2015","unstructured":"Llosa NJ, Cruise M, Tam A, Wicks EC, Hechenbleikner EM, Taube JM et al (2015) The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov 5(1):43\u201351","journal-title":"Cancer Discov"},{"issue":"17","key":"548_CR109","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1158\/1078-0432.CCR-19-3517","volume":"26","author":"M Kloor","year":"2020","unstructured":"Kloor M, Reuschenbach M, Pauligk C, Karbach J, Rafiyan MR, Al-Batran SE et al (2020) A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I\/IIa Clinical Trial. Clin Cancer Res 26(17):4503\u20134510","journal-title":"Clin Cancer Res"},{"issue":"4","key":"548_CR110","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1053\/j.gastro.2021.06.073","volume":"161","author":"J Gebert","year":"2021","unstructured":"Gebert J, Gelincik O, Oezcan-Wahlbrink M, Marshall JD, Hernandez-Sanchez A, Urban K et al (2021) Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model. Gastroenterology 161(4):1288\u2013302e13","journal-title":"Gastroenterology"},{"key":"548_CR111","unstructured":"Phase III (2022) Study of a Frameshift Peptide-based Vaccine in Lynch Syndrome Carriers (NCT05078866): ClinicalTrials.gov; [Available from: https:\/\/clinicaltrials.gov\/study\/NCT05078866"},{"key":"548_CR112","unstructured":"Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI (NCT01885702): ClinicalTrials.gov; 2010 [Available from: https:\/\/clinicaltrials.gov\/study\/NCT01885702?cond=Lynch%20Syndrome&intr=Vaccine&rank=3&a=15"},{"key":"548_CR113","unstructured":"Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome (NCT05419011): ClinicalTrials.gov; 2023 [cited 2025 Nov 21]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05419011?cond=Lynch%20Syndrome&intr=Vaccine&rank=2"},{"issue":"4","key":"548_CR114","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/jn\/nxz268","volume":"150","author":"SK Clinton","year":"2020","unstructured":"Clinton SK, Giovannucci EL, Hursting SD, The World Cancer Research Fund\/American Institute for Cancer Research Third Expert (2020) Report on Diet, Nutrition, Physical Activity, and Cancer: Impact and Future Directions. J Nutr 150(4):663\u2013671","journal-title":"J Nutr"},{"issue":"1","key":"548_CR115","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12916-024-03362-7","volume":"22","author":"K Matta","year":"2024","unstructured":"Matta K, Viallon V, Botteri E, Peveri G, Dahm C, Nannsen A et al (2024) Healthy lifestyle change and all-cause and cancer mortality in the European Prospective Investigation into Cancer and Nutrition cohort. BMC Med 22(1):210","journal-title":"BMC Med"},{"issue":"4","key":"548_CR116","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10689-019-00135-7","volume":"18","author":"AM Coletta","year":"2019","unstructured":"Coletta AM, Peterson SK, Gatus LA, Krause KJ, Schembre SM, Gilchrist SC et al (2019) Energy balance related lifestyle factors and risk of endometrial and colorectal cancer among individuals with lynch syndrome: a systematic review. Fam Cancer 18(4):399\u2013420","journal-title":"Fam Cancer"},{"issue":"3","key":"548_CR117","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/bjc.2016.193","volume":"115","author":"S Staff","year":"2016","unstructured":"Staff S, Aaltonen M, Huhtala H, Pylv\u00e4n\u00e4inen K, Mecklin JP, M\u00e4enp\u00e4\u00e4 J (2016) Endometrial cancer risk factors among Lynch syndrome women: a retrospective cohort study. Br J Cancer 115(3):375\u2013381","journal-title":"Br J Cancer"},{"key":"548_CR118","doi-asserted-by":"publisher","first-page":"e2300196","DOI":"10.1200\/PO.23.00196","volume":"8","author":"RF Power","year":"2024","unstructured":"Power RF, Doherty DE, Parker I, Gallagher DJ, Lowery MA, Cadoo KA (2024) Modifiable Risk Factors and Risk of Colorectal and Endometrial Cancers in Lynch Syndrome: A Systematic Review and Meta-Analysis. JCO Precis Oncol 8:e2300196","journal-title":"JCO Precis Oncol"},{"issue":"6","key":"548_CR119","doi-asserted-by":"publisher","first-page":"e0130018","DOI":"10.1371\/journal.pone.0130018","volume":"10","author":"AB Kamiza","year":"2015","unstructured":"Kamiza AB, Hsieh LL, Tang R, Chien HT, Lai CH, Chiu LL et al (2015) Risk Factors Associated with Colorectal Cancer in a Subset of Patients with Mutations in MLH1 and MSH2 in Taiwan Fulfilling the Amsterdam II Criteria for Lynch Syndrome. PLoS ONE 10(6):e0130018","journal-title":"PLoS ONE"},{"issue":"9","key":"548_CR120","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1002\/ijc.31611","volume":"143","author":"SG Dashti","year":"2018","unstructured":"Dashti SG, Win AK, Hardikar SS, Glombicki SE, Mallenahalli S, Thirumurthi S et al (2018) Physical activity and the risk of colorectal cancer in Lynch syndrome. Int J Cancer 143(9):2250\u20132260","journal-title":"Int J Cancer"},{"issue":"12","key":"548_CR121","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1136\/ijgc-2020-001879","volume":"30","author":"MG Inci","year":"2020","unstructured":"Inci MG, Richter R, Woopen H, Rasch J, Heise K, Anders L et al (2020) Role of predictive markers for severe postoperative complications in gynecological cancer surgery: a prospective study (RISC-Gyn Trial). Int J Gynecol Cancer 30(12):1975\u20131982","journal-title":"Int J Gynecol Cancer"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00548-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-026-00548-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00548-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:46:20Z","timestamp":1781642780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-026-00548-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":121,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["548"],"URL":"https:\/\/doi.org\/10.1007\/s10689-026-00548-1","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Kevin JJ Kwinten, Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands, kevin.kwinten@radboudumc.nl.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Corresponding author"}}],"article-number":"33"}}